Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital ...

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

One day in early May, web-based prediction market platform Kalshi listed two contracts tied to Compass Pathways’ psilocybin ...

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...

On this week’s episode of “The Readout LOUD,” the hosts discuss STAT's Breakthrough Summit West, where powerful leaders from ...

Vir Biotechnology develops immunology-based therapies targeting infectious diseases through global partnerships and scientific innovation.

Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.

May 20 (Reuters) - U.S. officials are working with a small biotechnology firm to make an experimental Ebola treatment available for people who may have been exposed to the virus, Bloomberg News ...